Liu H N, Molina-Holgado E, Almazan G
Department of Pharmacology and Therapeutics, McGill University, Montreal, Que., Canada.
Eur J Pharmacol. 1997 Nov 12;338(3):277-87. doi: 10.1016/s0014-2999(97)81931-0.
The effect of glutamate on the accumulation of [3H]inositol phosphates was examined in oligodendrocyte progenitor cultures prepared from rat brains. Glutamate, and the analogues alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and kainate, caused a concentration- and time-dependent increase in [3H]inositol trisphosphate (IP3) formation and the effect was blocked by 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), a competitive AMPA and kainate receptor antagonist. Similarly, the more selective, noncompetitive antagonist of AMPA receptors, 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine (GYKI 52466), significantly reduced the effect of both AMPA and kainate. In contrast, antagonists of N-methyl-D-aspartate (NMDA) receptor, (5R,10S)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclo-hepten-5, 10-imine (MK-801) and R(-)-3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP), and antagonists of metabotropic receptors, L(+)-2-amino-3-phosphono-propanoic acid (L-AP3) and alpha-methyl-4-carboxyphenylglycine (MCPG), were ineffective. These results suggest that the effect of glutamate on [3H]IP3 accumulation is mediated through ionotropic AMPA receptors. Cyclothiazide, an inhibitor of AMPA receptor desensitization, strongly potentiated the AMPA and kainate-stimulated [3H]IP3 formation as well as the uptake of 45Ca2+ in line with the previous findings. 45Ca2+ uptake evoked by AMPA or kainate, in combination with cyclothiazide, was also prevented by both CNQX and GYKI 52466. Glutamate-stimulated [3H]IP3 accumulation was prevented by EGTA, suggesting a requirement for extracellular calcium. Pre-incubation with the voltage-gated Ca2+ channel blockers, diltiazem, nifedipine and CdCl2, partially prevented the glutamate-induced [3H]IP3 accumulation as well as 45Ca2+ uptake. Similarly, the Na+/Ca2+ exchanger blockers benzamil and 3,4-dichlorobenzamil reduced significantly kainate-stimulated 45Ca2+ uptake. These data indicate that glutamate-induced [3H]IP3 accumulation is triggered by calcium influx via AMPA receptors, voltage-gated calcium channels and the Na+/Ca2+ exchanger operating in reverse mode.
在从大鼠脑制备的少突胶质前体细胞培养物中检测了谷氨酸对[3H]肌醇磷酸积累的影响。谷氨酸以及类似物α-氨基-3-羟基-5-甲基异恶唑-4-丙酸(AMPA)和海人藻酸,导致[3H]肌醇三磷酸(IP3)形成呈浓度和时间依赖性增加,且该效应被6-氰基-7-硝基喹喔啉-2,3-二酮(CNQX)阻断,CNQX是一种竞争性AMPA和海人藻酸受体拮抗剂。同样,AMPA受体更具选择性的非竞争性拮抗剂1-(4-氨基苯基)-4-甲基-7,8-亚甲基二氧基-5H-2,3-苯并二氮杂卓(GYKI 52466),显著降低了AMPA和海人藻酸的效应。相比之下,N-甲基-D-天冬氨酸(NMDA)受体拮抗剂(5R,10S)-(+)-5-甲基-10,11-二氢-5H-二苯并[a,d]环庚烯-5,10-亚胺(MK-801)和R(-)-3-(2-羧基哌嗪-4-基)-丙基-1-膦酸(CPP),以及代谢型受体拮抗剂L(+)-2-氨基-3-膦酰基丙酸(L-AP3)和α-甲基-4-羧基苯基甘氨酸(MCPG)均无效。这些结果表明,谷氨酸对[3H]IP3积累的影响是通过离子型AMPA受体介导的。环噻嗪是一种AMPA受体脱敏抑制剂,与先前的研究结果一致,它强烈增强了AMPA和海人藻酸刺激的[3H]IP3形成以及45Ca2+的摄取。CNQX和GYKI 5246也能阻止AMPA或海人藻酸与环噻嗪联合引起的45Ca2+摄取。EGTA可阻止谷氨酸刺激的[3H]IP3积累,表明需要细胞外钙。用电压门控Ca2+通道阻滞剂地尔硫卓、硝苯地平和CdCl2预孵育,可部分阻止谷氨酸诱导的[3H]IP3积累以及45Ca2+摄取。同样,Na+/Ca2+交换体阻滞剂苯甲酰米和3,4-二氯苯甲酰米显著降低了海人藻酸刺激的45Ca2+摄取。这些数据表明,谷氨酸诱导的[3H]IP3积累是由通过AMPA受体、电压门控钙通道和反向运作的Na+/Ca2+交换体的钙内流触发的。